Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled DiabetesJunichi Matsubara, Hisao Ogawa, Seigo Sugiyama et al.|Circulation Journal|2013Cited by 199
Acutely Decompensated Heart Failure with Preserved and Reduced Ejection Fraction Present with Comparable Haemodynamic CongestionLucas Van Aelst, Marie‐France Seronde, Mattia Arrigo et al.|European Journal of Heart Failure|2017Cited by 156
Long-Term Safety of Intravenous Cardiovascular Agents in Acute Heart Failure: Results from the European Society of Cardiology Heart Failure Long-Term RegistryAlexandre Mebazaa, Gerasimos Filippatos, Justina Motiejūnaitė et al.|European Journal of Heart Failure|2017Cited by 113
Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery DiseaseKeisuke Ohba, Hisao Ogawa, Toshimitsu Nozaki et al.|Journal of the American Heart Association|2012Cited by 110
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart FailureLeong L. Ng, Christian Mueller, Iain Squire et al.|Journal of the American College of Cardiology|2017Cited by 90